July 15, 2020 -- InvestorsHub NewsWire -- via Jelena Martinovic , Benzinga Staff Writer 

 

PAO Group Inc. (USOTC: PAOG), which operates as a physicians practice management company, confirmed its senior management team has obtained majority control of the company.

PAO Chief Executive James DiPrima has bought preferred stock from a third party and intends to continue serving at the helm of the company.

The management team has created a new medical cannabis strategy aimed to revitalize their "original mission to provide patient care alternatives to traditional patient care solutions," DiPrima explained.

The strategy includes the completion of the acquisitions of NCM Biotech from Kali-Extracts Inc. (OTCPK: KALY), and a cannabis cultivation operation from Puration Inc. (OTCPK: PURA), which are underway for months.

In addition, Puration announced the sale of its cultivation business on Friday.

The Dallas-based company had spun-off its cannabis cultivation operation to Nouveau (OTC: NOUV) earlier, in exchange for common stock.

"Our revitalization plan involves a complete exit of our previous endeavors and the implementation of an all new initiative through the planned acquisition of two currently operating businesses within the medical cannabis sector," DiPrima said.

Original Publication: https://www.benzinga.com/markets/cannabis/20/07/16618688/pao-group-confirms-takeover-looks-to-acquire-puration-and-kali-extracts

 

SOURCE: Jelena Martinovic , Benzinga Staff Writer 

Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025 Haga Click aquí para más Gráficas Nouveau Life Pharmaceuti... (PK).
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025 Haga Click aquí para más Gráficas Nouveau Life Pharmaceuti... (PK).